Lin YS - Search Results

1

Pharmacokinetics and safety of bevacizumab administered in combination with cisplatin and paclitaxel in cynomolgus monkeys.

Xu L, Zuch CL, Lin YS, Modi NB, Lum BL. Xu L, et al. Among authors: lin ys. Cancer Chemother Pharmacol. 2008 Apr;61(4):607-14. doi: 10.1007/s00280-007-0513-9. Epub 2007 Jun 5. Cancer Chemother Pharmacol. 2008. PMID: 17549476

2

Pharmacokinetics and pharmacodynamics of sibrafiban (Ro 48-3657), an orally active IIb/IIIa antagonist, administered alone or in combination with heparin, aspirin, and recombinant tissue-type plasminogen activator in beagles.

Modi NB, Lin YS, Reynolds T, Shaheen A, Christian BJ. Modi NB, et al. Among authors: lin ys. J Cardiovasc Pharmacol. 1998 Sep;32(3):397-405. doi: 10.1097/00005344-199809000-00010. J Cardiovasc Pharmacol. 1998. PMID: 9733353

3

Preclinical pharmacokinetics, interspecies scaling, and tissue distribution of a humanized monoclonal antibody against vascular endothelial growth factor.

Lin YS, Nguyen C, Mendoza JL, Escandon E, Fei D, Meng YG, Modi NB. Lin YS, et al. J Pharmacol Exp Ther. 1999 Jan;288(1):371-8. J Pharmacol Exp Ther. 1999. PMID: 9862791

4

Determination of Ro 48-3656 in rat plasma by reversed-phase high-performance liquid chromatography. Comparison of 1.5-microm nonporous silica to 3.5-microm porous silica analytical columns.

Paasch BD, Lin YS, Porter S, Modi NB, Barder TJ. Paasch BD, et al. Among authors: lin ys. J Chromatogr B Biomed Sci Appl. 1997 Dec 19;704(1-2):231-42. doi: 10.1016/s0378-4347(97)00418-0. J Chromatogr B Biomed Sci Appl. 1997. PMID: 9518155

5

Selective clearance of glycoforms of a complex glycoprotein pharmaceutical caused by terminal N-acetylglucosamine is similar in humans and cynomolgus monkeys.

Jones AJ, Papac DI, Chin EH, Keck R, Baughman SA, Lin YS, Kneer J, Battersby JE. Jones AJ, et al. Among authors: lin ys. Glycobiology. 2007 May;17(5):529-40. doi: 10.1093/glycob/cwm017. Epub 2007 Mar 1. Glycobiology. 2007. PMID: 17331977

6

Typhoid Fever as a Cause of Liver Failure in the United States: A Case Report.

Baqir SM, Sharma N, Lutaf A, Ghitan M, Lin YS. Baqir SM, et al. Among authors: lin ys. Case Rep Gastrointest Med. 2025 Jan 13;2025:3087201. doi: 10.1155/crgm/3087201. eCollection 2025. Case Rep Gastrointest Med. 2025. PMID: 39840122 Free PMC article.

7

Identifying New Susceptibility Genes of Non-Syndromic Orofacial Cleft Based on Syndromes Accompanied With Craniosynostosis.

Zhang SD, Lin YS, Shi B, Jia ZL. Zhang SD, et al. Among authors: lin ys. Cleft Palate Craniofac J. 2025 Jan 22:10556656251313842. doi: 10.1177/10556656251313842. Online ahead of print. Cleft Palate Craniofac J. 2025. PMID: 39838884

8

Posterior nasal nerve neurolysis in addition to radiofrequency ablation of the inferior turbinates for patients with chronic rhinitis.

Huang CY, Liao JY, Teng HL, Kang BH, Lin YS, Hsieh JW. Huang CY, et al. Among authors: lin ys. ORL J Otorhinolaryngol Relat Spec. 2025 Jan 14:1-21. doi: 10.1159/000543366. Online ahead of print. ORL J Otorhinolaryngol Relat Spec. 2025. PMID: 39809226

9

Unmasking tuberculous arthritis in a prosthetic joint: Diagnostic and therapeutic challenges.

Rahman A, Randhawa A, Lin YS. Rahman A, et al. Among authors: lin ys. IDCases. 2024 Dec 17;39:e02134. doi: 10.1016/j.idcr.2024.e02134. eCollection 2025. IDCases. 2024. PMID: 39801745 Free PMC article.

10

Tunable MEMS-based meta-absorbers for nondispersive infrared gas sensing applications.

Li K, Liang Y, Liu Y, Lin YS. Li K, et al. Among authors: lin ys. Microsyst Nanoeng. 2025 Jan 8;11(1):2. doi: 10.1038/s41378-024-00851-w. Microsyst Nanoeng. 2025. PMID: 39774094 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,300 results

Search Page

Filters